Meeting Program Committee
Program Committee Co-Chairs:
Lou Garrison, PhD
Lou Garrison, PhD
Professor, Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA
Penny Mohr, MA
Penny Mohr, MA
Senior Program Officer, Improving Healthcare Systems, Patient-Centered Outcomes Research Institute (PCORI), Washington, DC, USA
Research Review Committee Co-Chairs:
Carl V. Asche, MBA, MSc, PhD
Carl V. Asche, MBA, MSc, PhD
Research Professor of Medicine and Director, Center for Outcomes Research, University of Illinois College of Medicine at Peoria, Peoria, IL, USA
James D. Chambers, PhD, MPharm, MSc
James D. Chambers, PhD, MPharm, MSc
Assistant Professor, The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
Jean Lachaine, PhD
Jean Lachaine, PhD
Professor, University of Montreal and President, PeriPharm, Inc., Montreal, QC, Canada
Patrick W. Sullivan, PhD
Patrick W. Sullivan, PhD
Professor, Regis University School of Pharmacy, Denver, CO, USA
Issue Panel Review Committee Co-Chairs:
Chris Leibman, MS, PharmD
Chris Leibman, MS, PharmD
Vice President, HEOR – Global Market Access, Biogen, Cambridge, MA, USA
Brian Rittenhouse, PhD
Brian Rittenhouse, PhD
Associate Professor of Social and Administrative Sciences, Massachusetts College of Pharmacy and Health Sciences (MCPHS) University, Boston, MA, USA
Workshop Review Committee Co-Chairs:
Tanisha Carino, PhD
Tanisha Carino, PhD
Executive Vice President, Avalere Health, Washington, DC, USA
Shelby D. Reed, PhD, RPh
Shelby D. Reed, PhD, RPh
Professor, Department of Medicine, Center for Clinical and Genetic Economics, Duke Clinical Research Institute and Member, Duke Cancer Institute, Durham, NC, USA
Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.